Morocco: Dr Oualla completed her medical training at University Sidi Mohamed Ben Abdellahprior to practicing as a Medical Oncologist at Hassan II University Hospital. She alsoearned a degree in epidemiology and clinical research from University Sidi MohamedBen AbdellahthenjoinedInstitut Jules Bordet in Brussels, Belgium, as an assistantdoctor (2012–2013).Dr Oualla holds a certificate of specialization in MedicalOncology from the Université Libre de Bruxelles, and completed a 3-yearpostgraduate course in Medical Oncology (European Organisation for Research andTreatment of Cancer [EORTC]-affiliated National Belgian Programme for Inter-University Faculty).
Dr Ouallawas awarded a fellowship by the European Society of Medical Oncology(ESMO)on Onco-Urologyat the Istituto Nazionale dei Tumori, in Milan, Italywhereshe workedin Onco-UrologyUnit. In 2015, she joined the Cancer Prevention andControl Research Training Programme at the Department of Public Health in theUniversity of South Florida, in Tampa, FL, USA, funded by the National Institutes ofHealth (NIH) Fogarty International Center, Bethesda, MD, USA, and Moffitt CancerCenter, Tampa (2015–2016), where shegraduatedon “Concepts and Tools ofEpidemiology”. In 2016, Dr Oualla undertook transitional research training at theComprehensive Cancer Center (CCC), in Vienna, Austria, and completed an ESMOfellowship in the Palliative Care Department at the Centre Léon Bérard, in Lyon,France, in 2019.
She completed a master’s degree in Science at Ulm University, inUlm, Germany in 2020.Dr Oualla was designated as an ambassador of the European School of Oncology forthe years 2023 and 2024.Dr Ouallaserves on the leadership Council of the Global Society of RareGenitourinary Tumors (GSRGT),and the scientific committee of the InternationalBladder Cancer Group (IBCG). Sheis also member of ESMO,the American Societyof Clinical Oncology (ASCO), the European School of Oncology (ESO
